Abstract
Background:
A potential larger perceived placebo effect in children compared with adults could influence the detection of the treatment effect and the extrapolation of the treatment benefit from adults to children. This study aims to explore this potential difference, using a meta-epidemiological approach.
Methods:
A systematic review of the literature was done to identify trials included in meta-analyses evaluating a drug intervention with separate data for adults and children. The standardized mean change and the proportion of responders (binary outcomes) were used to calculate the perceived placebo effect. A meta-regression analysis was conducted to test for the difference between adults and children of the perceived placebo effect.
Results:
For binary outcomes, the perceived placebo effect was significantly more favorable in children compared with adults (β = 0.13; P = 0.001). Parallel group trials (β = −1.83; P < 0.001), subjective outcomes (β = −0.76; P < 0.001), and the disease type significantly influenced the perceived placebo effect.
Conclusion:
The perceived placebo effect is different between adults and children for binary outcomes. This difference seems to be influenced by the design, the disease, and outcomes. Calibration of new studies for children should consider cautiously the placebo effect in children.
Similar content being viewed by others
Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
References
Wolf S. The pharmacology of placebos. Pharmacol Rev 1959;11:689–704.
Boussageon R, Gueyffier F, Moreau A, Boussageon V. [The difficulty of measurement of placebo effect]. Therapie 2006;61:185–90.
Hrobjartsson A, Gotzsche PC. Placebo interventions for all clinical conditions. Cochrane Database Syst Rev 2010: CD003974.
Kaptchuk TJ, Kelley JM, Conboy LA, et al. Components of placebo effect: randomised controlled trial in patients with irritable bowel syndrome. BMJ 2008;336:999–1003.
Benedetti F. Placebo effects: from the neurobiological paradigm to translational implications. Neuron 2014;84:623–37.
Stein N, Sprenger C, Scholz J, Wiech K, Bingel U. White matter integrity of the descending pain modulatory system is associated with interindividual differences in placebo analgesia. Pain 2012;153:2210–7.
Ernst E. Placebo: new insights into an old enigma. Drug Discov Today 2007;12:413–8.
Beecher HK. The powerful placebo. J Am Med Assoc 1955;159:1602–6.
Ernst E, Resch KL. Concept of true and perceived placebo effects. BMJ 1995;311:551–3.
Fisher S. Nonspecific factors as determinants of behavioral response to drugs. In: Di Mascio A, Shader RI (eds.). Clinical Handbook of Psychopharmacology. New York: Science House 1971: 17–39.
Gøtzsche PC. Is there logic in the placebo? Lancet 1994;344:925–6.
Weimer K, Gulewitsch MD, Schlarb AA, Schwille-Kiuntke J, Klosterhalfen S, Enck P. Placebo effects in children: a review. Pediatr Res 2013;74:96–102.
Klassen TP, Hartling L, Craig JC, Offringa M. Children are not just small adults: the urgent need for high-quality trial evidence in children. PLoS Med 2008;5:e172.
Janiaud P, Lajoinie A, Cour-Andlauer F, et al. Different treatment benefits were estimated by clinical trials performed in adults compared with those performed in children. J Clin Epidemiol 2015;68:1221–31.
Rheims S, Cucherat M, Arzimanoglou A, Ryvlin P. Greater response to placebo in children than in adults: a systematic review and meta-analysis in drug-resistant partial epilepsy. PLoS Med 2008;5:e166.
Curie A, Yang K, Kirsch I, et al. Placebo responses in genetically determined intellectual disability: a meta-analysis. PLoS One 2015;10:e0133316.
Grelotti DJ, Kaptchuk TJ. Placebo by proxy. BMJ 2011;343:d4345.
Adams Nick P, Bestall Janine C, Lasserson Toby J, Jones P, Cates Christopher J. Fluticasone versus placebo for chronic asthma in adults and children. Cochrane Database of Syst Rev 2008: CD003135.
Adams Nick P, Bestall Janine C, Malouf R, Lasserson Toby J, Jones P. Beclomethasone versus placebo for chronic asthma. Cochrane Database of Syst Rev 2005: CD002738.
Adams Stephen P, Sekhon Sarpreet S, Wright James M. Lipid-lowering efficacy of rosuvastatin. Cochrane Database of Syst Rev 2014: CD010254.
Ashcroft DM, Dimmock P, Garside R, Stein K, Williams HC. Efficacy and tolerability of topical pimecrolimus and tacrolimus in the treatment of atopic dermatitis: meta-analysis of randomised controlled trials. BMJ 2005;330:516.
Barbui C, Cipriani A, Patel V, Ayuso-Mateos JL, van Ommeren M. Efficacy of antidepressants and benzodiazepines in minor depression: systematic review and meta-analysis. Br J Psychiatry 2011;198:11–6, sup 1.
Beyenburg S, Stavem K, Schmidt D. Placebo-corrected efficacy of modern antiepileptic drugs for refractory epilepsy: systematic review and meta-analysis. Epilepsia 2010;51:7–26.
Björkhem-Bergman L, Asplund AB, Lindh JD. Metformin for weight reduction in non-diabetic patients on antipsychotic drugs: a systematic review and meta-analysis. J Psychopharmacol 2011;25:299–305.
Bonini M, Di Mambro C, Calderon Moises A, et al. Beta2-agonists for exercise-induced asthma. Cochrane Database of Syst Rev 2013: CD003564.
Brown R, Taylor Matthew J, Geddes J. Aripiprazole alone or in combination for acute mania. Cochrane Database of Syst Rev 2013: CD005000.
Correll CU, Sheridan EM, DelBello MP. Antipsychotic and mood stabilizer efficacy and tolerability in pediatric and adult patients with bipolar I mania: a comparative analysis of acute, randomized, placebo-controlled trials. Bipolar Disord 2010;12:116–41.
Ducharme Francine M, Ni Chroinin M, Greenstone I, Lasserson Toby J. Addition of long-acting beta2-agonists to inhaled corticosteroids versus same dose inhaled corticosteroids for chronic asthma in adults and children. Cochrane Database of Syst Rev 2010: CD005535.
Dwan K, Phillipi Carrie A, Steiner Robert D, Basel D. Bisphosphonate therapy for osteogenesis imperfecta. Cochrane Database of Syst Rev 2014: CD005088.
Fang Y, Wu X, Xu L, et al. Randomized-controlled trials of levetiracetam as an adjunctive therapy in epilepsy of multiple seizure types. J Clin Neurosci 2014;21:55–62.
Ferracioli-Oda E, Qawasmi A, Bloch MH. Meta-analysis: melatonin for the treatment of primary sleep disorders. PLoS One 2013;8:e63773.
Hayward G, Thompson Matthew J, Perera R, Glasziou Paul P, Del Mar Chris B, Heneghan Carl J. Corticosteroids as standalone or add-on treatment for sore throat. Cochrane Database of Syst Rev 2012: CD008268.
Hidalgo RB, Tupler LA, Davidson JR. An effect-size analysis of pharmacologic treatments for generalized anxiety disorder. J Psychopharmacol 2007;21:864–72.
Jesner Ora S, Aref-Adib M, Coren E. Risperidone for autism spectrum disorder. Cochrane Database of Syst Rev 2007: CD005040.
Kim SO, Ah YM, Yu YM, Choi KH, Shin WG, Lee JY. Effects of probiotics for the treatment of atopic dermatitis: a meta-analysis of randomized controlled trials. Ann Allergy Asthma Immunol 2014;113:217–26.
Koh Mariko S, Tee A, Lasserson Toby J, Irving Louis B. Inhaled corticosteroids compared to placebo for prevention of exercise induced bronchoconstriction. Cochrane Database of Syst Rev 2007: CD002739.
Lands Larry C, Stanojevic S. Oral non-steroidal anti-inflammatory drug therapy for lung disease in cystic fibrosis. Cochrane Database of Syst Rev 2013: CD001505.
Manning P, Gibson Peter G, Lasserson Toby J. Ciclesonide versus placebo for chronic asthma in adults and children. Cochrane Database of Syst Rev 2008: CD006217.
Mason Anne R, Mason J, Cork M, Dooley G, Hancock H. Topical treatments for chronic plaque psoriasis. Cochrane Database of Syst Rev 2013: CD005028.
Mbizvo Gashirai K, Dixon P, Hutton Jane L, Marson Anthony G. Levetiracetam add-on for drug-resistant focal epilepsy: an updated Cochrane Review. Cochrane Database of Syst Rev 2012: CD001901.
Normansell R, Walker S, Milan Stephen J, Walters EH, Nair P. Omalizumab for asthma in adults and children. Cochrane Database of Syst Rev 2014: CD003559.
Pulman J, Jette N, Dykeman J, Hemming K, Hutton Jane L, Marson Anthony G. Topiramate add-on for drug-resistant partial epilepsy. Cochrane Database of Syst Rev 2014: CD001417.
Ramaratnam S, Marson Anthony G, Baker Gus A. Lamotrigine add-on for drug-resistant partial epilepsy. Cochrane Database of Syst Rev 2001: CD001909.
Southern Kevin W, Barker Pierre M, Solis-Moya A, Patel L. Macrolide antibiotics for cystic fibrosis. Cochrane Database of Syst Rev 2012: CD002203.
Spooner C, Saunders LD, Rowe Brian H. Nedocromil sodium for preventing exercise-induced bronchoconstriction. Cochrane Database of Syst Rev 2002: CD001183.
Suttajit S, Srisurapanont M, Maneeton N, Maneeton B. Quetiapine for acute bipolar depression: a systematic review and meta-analysis. Drug Des Devel Ther 2014;8:827–38.
Tonia T, Mettler A, Robert N, et al. Erythropoietin or darbepoetin for patients with cancer. Cochrane Database of Syst Rev 2012: CD003407.
Tsapakis EM, Soldani F, Tondo L, Baldessarini RJ. Efficacy of antidepressants in juvenile depression: meta-analysis. Br J Psychiatry 2008;193:10–7.
Walters EH, Gibson Peter G, Lasserson Toby J, Walters Julia AE. Long-acting beta2-agonists for chronic asthma in adults and children where background therapy contains varied or no inhaled corticosteroid. Cochrane Database of Syst Rev 2007: CD001385.
Watts K, Chavasse Richard JPG. Leukotriene receptor antagonists in addition to usual care for acute asthma in adults and children. Cochrane Database of Syst Rev 2012: CD006100.
Whiting P, Al M, Burgers L, et al. Ivacaftor for the treatment of patients with cystic fibrosis and the G551D mutation: a systematic review and cost-effectiveness analysis. Health Technol Assess 2014;18:1–106.
Evers S, Marziniak M, Frese A, Gralow I. Placebo efficacy in childhood and adolescence migraine: an analysis of double-blind and placebo-controlled studies. Cephalalgia 2009;29:436–44.
Rutherford BR, Mori S, Sneed JR, Pimontel MA, Roose SP. Contribution of spontaneous improvement to placebo response in depression: a meta-analytic review. J Psychiatr Res 2012;46:697–702.
Suchman AL, Ader R. Classic conditioning and placebo effects in crossover studies. Clin Pharmacol Ther 1992;52:372–7.
McDonald CJ, Mazzuca SA, McCabe GP Jr . How much of the placebo ‘effect’ is really statistical regression? Stat Med 1983;2:417–27.
Whalley B, Hyland ME. Placebo by proxy: the effect of parents’ beliefs on therapy for children’s temper tantrums. J Behav Med 2013;36:341–6.
Cohen D, Deniau E, Maturana A, et al. Are child and adolescent responses to placebo higher in major depression than in anxiety disorders? A systematic review of placebo-controlled trials. PLoS One 2008;3:e2632.
Lewis DW, Winner P, Wasiewski W. The placebo responder rate in children and adolescents. Headache 2005;45:232–9.
Higgins JPT, Green S. Cochrane Handbook for Systematic Reviews of Interventions. 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. (http://handbook.cochrane.org/).
Jadad AR, Enkin MW. Randomized Controlled Trials: Questions, Answers and Musings. 2nd edn. Oxford, UK: Blackwell Publishing Ltd, 2007: 48–61.
Acknowledgements
B.K. and M.C. were responsible for the study concept and design. B.K., A.L., C.C., A.D., and P.J. were involved in the literature and data extraction. M.C., B.K., C.C., and P.J. were responsible for the data analysis and interpretation. B.K. and P.J. wrote the manuscript. All authors critically revised the manuscript. B.K. and P.J. were responsible for the editing of the manuscript. B.K. supervised the study and is the guarantor.
Author information
Authors and Affiliations
Corresponding author
Supplementary information
Supplementary Figures and Tables
(ZIP 523 kb)
Rights and permissions
About this article
Cite this article
Janiaud, P., Cornu, C., Lajoinie, A. et al. Is the perceived placebo effect comparable between adults and children? A meta-regression analysis. Pediatr Res 81, 11–17 (2017). https://doi.org/10.1038/pr.2016.181
Received:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1038/pr.2016.181
This article is cited by
-
From stress to anhedonia: differential gene expression, behavioural and biochemical modulations in resilient versus susceptible mice in an ultrasound model of juvenile depression
Journal of Neural Transmission (2025)
-
Irritable bowel syndrome in children: the placebo response rate and influencing factors a meta-analysis
Pediatric Research (2024)
-
Long-term efficacy of HDM-SCIT in pediatric and adult patients with allergic rhinitis
Allergy, Asthma & Clinical Immunology (2023)
-
Improving treatment outcomes for adolescents with borderline personality disorder through a socioecological approach
Borderline Personality Disorder and Emotion Dysregulation (2022)
-
Placebo: a brief updated review
Naunyn-Schmiedeberg's Archives of Pharmacology (2022)
